| Title : Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications - Espay_2018_Mov.Disord_33_1769 |
| Author(s) : Espay AJ , Guskey MT , Norton JC , Coate B , Vizcarra JA , Ballard C , Factor SA , Friedman JH , Lang AE , Larsen NJ , Andersson C , Fredericks D , Weintraub D |
| Ref : Movement Disordersord , 33 :1769 , 2018 |
| Abstract : Espay_2018_Mov.Disord_33_1769 |
| ESTHER : Espay_2018_Mov.Disord_33_1769 |
| PubMedSearch : Espay_2018_Mov.Disord_33_1769 |
| PubMedID: 30387904 |
Espay AJ, Guskey MT, Norton JC, Coate B, Vizcarra JA, Ballard C, Factor SA, Friedman JH, Lang AE, Larsen NJ, Andersson C, Fredericks D, Weintraub D (2018)
Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications
Movement Disordersord
33 :1769
Espay AJ, Guskey MT, Norton JC, Coate B, Vizcarra JA, Ballard C, Factor SA, Friedman JH, Lang AE, Larsen NJ, Andersson C, Fredericks D, Weintraub D (2018)
Movement Disordersord
33 :1769